Cart
sales@molnova.com
Endoxifen E-isomer hydrochloride
CAS No. 1197194-61-8
Endoxifen E-isomer hydrochloride( E-Endoxifen hydrochloride )
Catalog No. M17183 CAS No. 1197194-61-8
Endoxifen, a tamoxifen metabolite, is effective specific Estrogen Response Modifier (SERM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 182 | In Stock |
|
| 5MG | 202 | In Stock |
|
| 10MG | 299 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEndoxifen E-isomer hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionEndoxifen, a tamoxifen metabolite, is effective specific Estrogen Response Modifier (SERM).
-
DescriptionEndoxifen, a tamoxifen metabolite, is effective specific Estrogen Response Modifier (SERM).
-
In VitroEndoxifen E-isomer (1-1000 nM; 12 h) inhibits PGR gene expression in E2-induced MCF-7 cells.
-
In Vivo——
-
SynonymsE-Endoxifen hydrochloride
-
PathwayProteasome/Ubiquitin
-
TargetTyrosinase
-
RecptorERR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1197194-61-8
-
Formula Weight409.95
-
Molecular FormulaC25H28ClNO2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 30 mg/mL. 73.18 mM
-
SMILESCC/C(=C(/c1ccc(cc1)O)\c1ccc(cc1)OCCNC)/c1ccccc1.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chae YJ, et al. Eur J Pharmacol. 2015 Apr 5;752:1-7.
molnova catalog
related products
-
2-(4-(4-methoxybenzy...
Detail unknown.
-
D-Tyrosine
D-Tyrosine negatively regulates melanin synthesis by inhibiting tyrosinase activity. D-Tyrosine is the D-isomer of tyrosine. D-Tyrosine inhibits biofilm formation and trigger the self-dispersal of biofilms without suppressing bacterial growth.
-
NDI-034858
NDI-034858 (TAK-279) is a tyrosine kinase 2 (TYK2) inhibitor (Kd<200 pM) that targets the JH2 structural domain of Tyk2 for the treatment of autoimmune diseases caused by aberrant expression of IL12 and IL23.
